Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J
Cancer Res. 1983 Feb;43(2):736-42.
Monoclonal antibody B6.2 reacts with a protein found on the surface of primary and metastatic human mammary tumors. B6.2 immunoglobulin G (IgG) was purified, F(ab')2 and Fab' fragments were generated by pepsin digestion, and the IgG and its fragments were radiolabeled with 125I; all were successful in localizing human mammary tumors transplanted into athymic mice, with tumor:tissue ratios increasing over a 4-day period. The 125I-labeled IgG gave tumor:spleen, tumor:liver, and tumor:kidney ratios of greater than 10:1 and tumor:brain and tumor:muscle ratios of 50:1 to 110:1. The F(ab')2 fragment gave higher tumor:tissue ratios than did the IgG, with tumor:liver and tumor:spleen ratios of 15:1 to 20:1. No localization of the labeled B6.2 monoclonal antibody or its fragments was observed in athymic mice bearing a human melanoma or with isotype-identical control immunoglobulin or its fragments in athymic mice bearing the mammary tumors. Imaging experiments confirmed the ability of radiolabeled monoclonal antibody B6.2 and its fragments to detect the presence of transplanted human mammary tumor lesions of less than 0.4 cm without the aid of background subtraction manipulations.
单克隆抗体B6.2可与原发性和转移性人类乳腺肿瘤表面发现的一种蛋白质发生反应。纯化了B6.2免疫球蛋白G(IgG),通过胃蛋白酶消化产生F(ab')2和Fab'片段,并用125I对IgG及其片段进行放射性标记;所有这些都成功地定位了移植到无胸腺小鼠体内的人类乳腺肿瘤,肿瘤与组织的比率在4天内有所增加。125I标记的IgG的肿瘤与脾脏、肿瘤与肝脏以及肿瘤与肾脏的比率大于10:1,肿瘤与大脑以及肿瘤与肌肉的比率为50:1至110:1。F(ab')2片段的肿瘤与组织比率高于IgG,肿瘤与肝脏以及肿瘤与脾脏的比率为15:1至20:1。在患有人类黑色素瘤的无胸腺小鼠中,或在患有乳腺肿瘤的无胸腺小鼠中,未观察到标记的B6.2单克隆抗体或其片段与同型对照免疫球蛋白或其片段的定位。成像实验证实,放射性标记的单克隆抗体B6.2及其片段能够在不借助背景扣除操作的情况下检测到小于0.4厘米的移植人类乳腺肿瘤病变的存在。